Carcinoma, Ovarian Epithelial: all 1,619 studies
Page 3 of 17. Open to participants first (245), then studies with results posted, then the rest; newest registration first within each.
- PET Imaging of Solid Tumors by a Novel Tracer, 68Ga-FAPIRecruitingNCT05172310Phase 1
- A Study of NX-1607 in Adults With Advanced MalignanciesRecruitingNCT05107674Phase 1
- Microtransplantation for Ovarian CancerRecruitingNCT05095558Phase 1/2
- A Beta-only IL-2 ImmunoTherapY StudyRecruitingNCT05086692Phase 1/2
- Adaptive ChemoTherapy for Ovarian Cancer in Patients With Replased Platinum-sensitive High Grade Serous or High Grade Endometrioid Ovarian CancerRecruitingNCT05080556Phase 2
- Using Genetic Profile to Determine the Treatment for Patients With Ovarian Cancer Who Previously Received a PARP-inhibitorRecruitingNCT05065021Phase 2
- ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy EvaluationRecruitingNCT05059444
- Transcriptional Map of Ovarian Cancer at the Single Cell LevelRecruitingNCT05030805
- 13C-Glucose Tracing of Tumour and T Cells in the Ascites of Ovarian Cancer Patients.RecruitingNCT05025878
- Chiauranib Plus Weekly Paclitaxel in Patients with Platinum-refractory or Platinum-resistant Recurrent Ovarian CancerRecruitingNCT04921527Phase 3
- Early Detection of Endometrial/Ovarian Cancer and Hereditary Predisposition of These CancersRecruitingNCT04891029Not applicable
- A Study of Maintenance DCVAC/OvCa After First-line Chemotherapy Added Standard of CareRecruitingNCT04834544Phase 2
- PD-1 Antibody Combined Neoadjuvant Chemotherapy for Ovarian CancerRecruitingNCT04815408Phase 2
- Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Associated With Systemic Chemotherapy in Women With Advanced Ovarian CancerRecruitingNCT04811703Phase 1
- Developing a Test of Uterine Lavage for the Detection of Ovarian CancerRecruitingNCT04794322
- A Comparison of 2 Standard Doses of Bevacizumab in Combination With Chemotherapy in Epithelial Ovarian CancerRecruitingNCT04787289Phase 2
- The Culture of Ovarian Cancer Organoids and Drug ScreeningRecruitingNCT04768270
- Efficacy of Neoadjuvant Therapy With Cisplatin Plus Mitomycin C in BRCA1-Mutated Ovarian CancerRecruitingNCT04747717Not applicable
- Lymphadenectomy in Early Ovarian CancerRecruitingNCT04710797Not applicable
- Efficacy and Adverse Effects of Olaparib in Ovarian Cancer.Enrolling by invitationNCT04699006
- Chk2 Inhibitor for Recurrent EpitheliAl periToneal, fallopIan or oVarian cancEr (CREATIVE Phase IA Trial)RecruitingNCT04678102Phase 1
- Rectosigmoid Resection vs Seromuscular Tumor Shaving in Ovarian Cancer SurgeryRecruitingNCT04665635Not applicable
- WoO: Window of Opportunity Trial of Olaparib and Durvalumab in Histologically Proven EOCRecruitingNCT04644289Phase 2
- Adjuvant Chemotherapy of Three-step Regimen in BRCA1/2 Wide Type Ovarian Cancer (ACTS-2)RecruitingNCT04520074Phase 3
- Pembrolizumab and Lenvatinib for Platinum- Sensitive Recurrent Ovarian CancerRecruitingNCT04519151Phase 2
- Fuzuloparib Arsenic Trioxide Platinum Resistance Relapsed Ovarian CancerRecruitingNCT04518501Phase 1/2
- A Study of Azenosertib (ZN-c3) in Patients With Ovarian CancerRecruitingNCT04516447Phase 1
- Stratified Evaluation of PDS and NACT-IDS in Ovarian Cancer (FOCUS)Not yet recruitingNCT04515602Phase 3
- Connected Prehabilitation Program During Neo Adjuvant ChemotherapyNot yet recruitingNCT04451369Not applicable
- Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid TumorsRecruitingNCT04429542Phase 1
- Factors Affecting the Prognosis of Early Ovarian CancerRecruitingNCT04414683
- Register to Describe the Treatment Pattern of Platinum-sensitive Relapsed Epithelial Ovarian Cancer Patients in AustriaRecruitingNCT04369352
- Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid MalignanciesRecruitingNCT04282044Phase 1
- BP1001-A in Patients With Advanced or Recurrent Solid TumorsRecruitingNCT04196257Phase 1
- Phase III Trial of Stage I Ovarian Cancer After SurgeryRecruitingNCT04063527Phase 3
- Overcoming Chemoresistance in Advanced Ovarian Cancer Via Targeting HypoxiaRecruitingNCT04001023Not applicable
- Surgery and Niraparib in Secondary Recurrent Ovarian Cancer (SOC-3 Trial)RecruitingNCT03983226Phase 2
- Development of a Cinical and Biological Database in Ovarian, Fallopian Tube and Peritoneal CancersRecruitingNCT03976999Not applicable
- Platino-resistance in Ovarian CancerRecruitingNCT03954171Not applicable
- Determining Prognostic Immune Markers in Patients With Ovarian CancerRecruitingNCT03862677
- Signal TrAnsduction Pathway Activity Analysis in OVarian cancERRecruitingNCT03458221Phase 2/3
- HIPEC in Ovarian Carcinoma Clinical Stage IIIC and IV During Interval LaparotomyRecruitingNCT03275194Phase 2
- Two Therapeutic Strategies in First-line in Patients With Epithelial Advanced Ovarian CancerRecruitingNCT03025477Phase 2
- Study of Tumor Tissue Samples From Patients Who Have Undergone Surgery for Advanced Stage III or Stage IV Ovarian Epithelial CancerRecruitingNCT01000259
- Specimen and Data Study for Ovarian Cancer Early Detection and PreventionRecruitingNCT00005095
- Study to Evaluate the Safety and Efficacy of TSR-042, Bevacizumab, and Niraparib in Participants With Recurrent Ovarian CancerCompletedNCT05751629Phase 2Results posted
- A Study of MORAb-202 Versus Investigator's Choice Chemotherapy in Female Participants With Platinum-resistant High-grade Serous (HGS) Ovarian, Primary Peritoneal, or Fallopian Tube CancerCompletedNCT05613088Phase 2Results posted
- Phase 1b Study of SL-172154 Administered With Combination Agent(s) in Subjects With Ovarian CancersCompletedNCT05483933Phase 1Results posted
- Study of Maplirpacept (PF-07901801) in Combination With PLD in Patients With Platinum-Resistant Ovarian CancerTerminatedNCT05261490Phase 1/2Results posted
- Pembrolizumab/Placebo Plus Paclitaxel With or Without Bevacizumab for Platinum-resistant Recurrent Ovarian Cancer (MK-3475-B96/KEYNOTE-B96/ENGOT-ov65).Active, not recruitingNCT05116189Phase 3Results posted
- Connecting Families to Overcome Ovarian CancerCompletedNCT04927013Not applicableResults posted
- Irinotecan Liposome and Bevacizumab for the Treatment of Platinum Resistant, Recurrent, or Refractory Ovarian, Fallopian Tube, or Primary Peritoneal CancerCompletedNCT04753216Phase 2Results posted
- CATCH-R: A Rollover Study to Provide Continued Access to RucaparibCompletedNCT04676334Phase 3Results posted
- Phase I Study of Autologous CAR T-Cells Targeting the B7-H3 Antigen in Recurrent Epithelial OvarianActive, not recruitingNCT04670068Phase 1Results posted
- FT516 and IL2 With Enoblituzumab for Ovarian CancerCompletedNCT04630769Phase 1Results posted
- BrUOG 390: Neoadjuvant Treatment With TalazoparibTerminatedNCT04598321Phase 1Results posted
- Analysis of the Clinical Experience With Rucaparib in the Rucaparib Access Program (RAP) in Spain - A GEICO StudyCompletedNCT04539327Results posted
- REVITALIZE: A Telehealth Intervention for Women With Advanced Ovarian Cancer and PARP Inhibitor-Related FatigueCompletedNCT04525183Not applicableResults posted
- PLX2853 as a Single Agent in Advanced Gynecological Malignancies and in Combination With Carboplatin in Platinum-Resistant Epithelial Ovarian CancerTerminatedNCT04493619Phase 1/2Results posted
- Trial Evaluating Feasibility and Quality of Life of Second Look Laparoscopy With Hyperthermic Intraperitoneal ChemotherapyCompletedNCT04415944Phase 2Results posted
- Phase 1 Study of SL-172154 (SIRPα-Fc-CD40L) in Subjects With Ovarian CancerCompletedNCT04406623Phase 1Results posted
- Delayed Initiation of Olaparib Maintenance Therapy in Platinum Sensitive Recurrent Ovarian CancerTerminatedNCT04377087Phase 2Results posted
- Aspirin for Prevention of Venous Thromboembolism Among Ovarian Cancer Patients Receiving Neoadjuvant ChemotherapyCompletedNCT04352439Phase 4Results posted
- Prospective Multicentre Phase-IV Clinical Trial of Olaparib in Indian Patients With Ovarian and Metastatic Breast CancerCompletedNCT04330040Phase 4Results posted
- A Study of Mirvetuximab Soravtansine in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha ExpressionCompletedNCT04296890Phase 3Results posted
- A Study of Mirvetuximab Soravtansine vs. Investigator's Choice (IC) of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha (FRα) ExpressionCompletedNCT04209855Phase 3Results posted
- AVB-S6-500 and Durvalumab in Treating Patients With Platinum-Resistant or Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal CancerTerminatedNCT04019288Phase 1/2Results posted
- Study to Evaluate the Efficacy and Safety of the Combination of Niraparib and Dostarlimab (TSR-042) in Participants With Platinum Resistant Ovarian CancerTerminatedNCT03955471Phase 2Results posted
- A Study Evaluating the Safety, Pharmacokinetics and Efficacy of Ipatasertib Administered in Combination With Rucaparib in Participants With Advanced Breast, Ovarian Cancer, and Prostate Cancer.CompletedNCT03840200Phase 1Results posted
- A Study to Evaluate Rucaparib in Combination With Nivolumab in Patients With Selected Solid Tumors (ARIES)TerminatedNCT03824704Phase 2Results posted
- European Trial on Enhanced DNA Repair Inhibition in Ovarian CancerCompletedNCT03783949Phase 2Results posted
- Japan Phase 2 Study of Niraparib in Participants With Advanced, Relapsed Ovarian CancerCompletedNCT03759600Phase 2Results posted
- Japan Phase 2 Study of Niraparib (Maintenance Therapy) in Participants With Relapsed Ovarian CancerCompletedNCT03759587Phase 2Results posted
- Phase Ib/II Study of Carboplatin + M6620 + Avelumab in PARPi-resistant Ovarian CancerCompletedNCT03704467Phase 1Results posted
- A Study of Weekly Tisotumab Vedotin for Patients With Platinum-Resistant Ovarian Cancer With Safety Run-in (innovaTV 208)CompletedNCT03657043Phase 2Results posted
- Avelumab and Talazoparib in Untreated Advanced Ovarian Cancer (JAVELIN OVARIAN PARP 100)TerminatedNCT03642132Phase 3Results posted
- The Effects of Exercise on Distress, Quality of Life, and Biomarkers in Ovarian Cancer SurvivorsTerminatedNCT03641287Not applicableResults posted
- Autologous Tumor Infiltrating Lymphocytes MDA-TIL in Treating Patients With Recurrent or Refractory Ovarian Cancer, Colorectal Cancer, or Pancreatic Ductal AdenocarcinomaTerminatedNCT03610490Phase 2Results posted
- Lavage of the Uterine Cavity for Diagnosis of Ovarian CancerTerminatedNCT03606486Not applicableResults posted
- Study of Magrolimab (Hu5F9-G4) in Combination With Avelumab in Solid Tumor Participants and Checkpoint-Inhibitor-Naive Ovarian Cancer Participants Who Progress Within 6 Months of Prior Platinum ChemotherapyCompletedNCT03558139Phase 1Results posted
- A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based ChemotherapyActive, not recruitingNCT03522246Phase 3Results posted
- A Study of PF-06873600 in People With CancerTerminatedNCT03519178Phase 1/2Results posted
- Trial of Trientine Plus Pegylated Liposomal Doxorubicin and Carboplatin in Epithelial Ovarian CancerCompletedNCT03480750Phase 1/2Results posted
- A Phase I Dose-escalation Study of Subcutaneous ALM201 in Patients With Advanced Ovarian Cancer and Other Solid TumoursTerminatedNCT03427073Phase 1Results posted
- A Study of Prexasertib (LY2606368) in Platinum-Resistant or Refractory Recurrent Ovarian CancerCompletedNCT03414047Phase 2Results posted
- Multicentre Study of Olaparib Maintenance Monotherapy in Platinum Sensitive Relapsed Non gBRCAm Ovarian Cancer PatientsCompletedNCT03402841Phase 3Results posted
- Atezolizumab With Neoadjuvant Chemotherapy for Patients With Newly-Diagnosed Advanced-Stage Ovarian CancerCompletedNCT03394885Phase 1/2Results posted
- Pilot Study of Denosumab in BRCA1/2 Mutation Carriers Scheduled for Risk-Reducing Salpingo-OophorectomyTerminatedNCT03382574Early Phase 1Results posted
- Stepping Into Survivorship: Harnessing Behavioral Economics to Improve Quality of Life in Ovarian CancerCompletedNCT03364673Not applicableResults posted
- A Study of DSP-7888 Dosing Emulsion in Combination With Immune Checkpoint Inhibitors in Adult Patients With Advanced Solid TumorsTerminatedNCT03311334Phase 1/2Results posted
- PIPAC Nab-pac for Stomach, Pancreas, Breast and Ovarian CancerCompletedNCT03304210Phase 1Results posted
- TIL Therapy in Combination With Checkpoint Inhibitors for Metastatic Ovarian CancerCompletedNCT03287674Phase 1/2Results posted
- p53 Activation in Platinum-Resistant High Grade Serous Ovarian Cancer, a Study of PLD With APR-246CompletedNCT03268382Phase 2Results posted
- Clinical Trial of Combined Fostamatinib and Paclitaxel in Ovarian CancerCompletedNCT03246074Phase 1Results posted
- OTL38 for Intra-operative Imaging of Folate Receptor Positive Ovarian CancerCompletedNCT03180307Phase 3Results posted
- QoL-Comparison Between Trabectedin/PLD and Pt-based Therapy in Patients With Pt-sensitive Recurrent Ovarian CancerTerminatedNCT03164980Phase 4Results posted
- Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With CancerCompletedNCT03154190Not applicableResults posted
- NUC-1031 in Patients With Platinum-Resistant Ovarian CancerTerminatedNCT03146663Phase 2Results posted
- A Study to Examine Olaparib Maintenance Retreatment in Patients With Epithelial Ovarian Cancer.CompletedNCT03106987Phase 3Results posted
- Evaluation of Weekly Ixabepilone With or Without Biweekly BevacizumabCompletedNCT03093155Phase 2Results posted